baber/WOPTO huggingface dataset:
Patent JP-2002503376-A (JP)
Title: 取外し可能なドライブキャリアのためのカム補助式取出しハンドル
IPC: H01R13/62
Filed: 1998-04-06
Abstract: (57)【要約】
コンピュータまたはワークステーションにおいて用いるための記憶装置のためのポータブルドライブキャリア（１）を説明する。キャリア（１）は、コンピュータまたはワークステーションの既存のドライブベイに一般的に装着されるＵ字型収容フレーム（２）からキャリア（１）を脱離し取出す上で助けとなるよう適合される回転可能なハンドル（８）を有する。キャリア（１）は、キャリア（１）のそれぞれの側部に結合されハンドル（８）の回転に対して側部に沿って移動する１対のハンドルカム（２５）を含む。ハンドルカム（２５）は収容フレーム（２）に係合するように移動し収容フレーム（２）に押付け力を加え、キャリアが収容フレームに対して前進させられ収容フレームから脱離し、キャリアをフレームから引張り出し取外すことができる。ハンドルカム（２５）はハンドル（８）に形成される力伝達面（４４）と接続されており、そのためハンドルの回転がハンドルカムに伝達され、ハンドルカムをキャリア（１）の側部に沿って移動させ、収容フレーム（２）に対して押付け力を加えるようにする。
Patent JP-2002506381-A (JP)
IPC: A47F3/04
Filed: 1999-04-20
Abstract: An environmental cabinet including at least two opening leaves which have an insulating glazing unit composed of at least two glass sheets between which a vacuum has been created. The sheets are joined together around their periphery by an inorganic seal. The sealing between the two opening leaves is achieved by a vertical member which overlaps the edges of both opening leaves and is fixed to one of the edges.
Patent MX-158460-A (MX)
Inventor: SOLOMON FRANK
IPC: H01M4/96
Filed: 1981-10-30
Abstract: This disclosure is directed to the preparation of cohesive, self-sustaining electrode backing layers by a method comprising mixing from 5 to 50 weight parts of polytetrafluoroethylene (PTFE) having a particle size ranging from 0.05 to 0.5 micron with from 95 to about 50 weight parts of carbon black of a particle size ranging from about 50 to 3000 angstroms and a density of about 1.95 grams per cubic centimeter, to produce an electrode backing layer having enhanced electrical conductivity compared to backing layers made from PTFE alone.
Patent NZ-221746-A (NZ)
Title: Self-supporting ceramic structures with polycrystalline ceramic occupying portion of original interconnecting porosity
Inventor: DWIVEDI RATNESH K
IPC: C04B41/87
Filed: 1987-09-09
Abstract: A method of producing self-supporting ceramic structures (12) comprising (i) a polycrystalline oxidation reaction product formed upon oxidation of a molten parent metal (14) with an oxidant, and (ii) interconnected porosity (13) at least partially accessible from one or more surfaces (15) of said ceramic body. A second polycrystalline ceramic material is incorporated into the porosity of said ceramic body to modify or contribute to its properties.
Patent NZ-225069-A (NZ)
Title: Preparation of monohalogenated cyclobutarenes
Inventor: MING-BIANN LIU
IPC: C07C25/18
Filed: 1988-06-17
Abstract: Monobrominated cyclobutarenes are prepared by brominating a cyclobutarene in the presence of an organic complexing agent, an acid scavenger, or water. Faster reaction rates highly selective to monobrominated cyclobutarenes are obtained without conventional heavy metal or halogen catalysts.
Patent NZ-232340-A (NZ)
Title: Alkoxy and hydroxy polymeric quaternary ammonium trihalides and their use in inhibiting growth of micro-organisms
Inventor: HOLLIS C GEORGE
IPC: A61P17/00
Filed: 1990-02-01
Abstract: Polymeric quaternary ammonium trihalides, preferably triiodides, and use of polymeric quaternary ammonium trihalides to inhibit the growth of microorganisms in aquatic systems, to disinfect or sanitize surfaces and to disinfect the skin of animals, including humans.
Patent NZ-233776-A (NZ)
Title: Pharmaceutical composition comprising a divalent metal salt complex of indomethacin, and method of treating inflammation and pain
Inventor: REGTOP HUBERTUS LEONARDUS
IPC: C07D209/28
Filed: 1990-05-22
Abstract: The present invention provides a method for the treatment of inflammation and pain in a mammal requiring such treatment, comprising administering to said mammal an anti-inflammatory and analgesically effective amount of an indomethacin salt of a divalent metal capable of forming a stable complex with indomethacin, or of a pharmaceutical composition comprising said indomethacin salt together with a pharmaceutically acceptable carrier, diluent and/or excipient. The present invention also provides a process for the preparation of an indomethacin salt of a divalent metal capable of forming a stable complex with indomethacin comprising forming a solution by dissolving indomethacin and a salt of said divalent metal in a tertiary amide or cyclic tertiary amide, adding a C1-4 alkanol or C3-6 ketone to the solution to precipitate the indomethacin metal salt and separating the indomethacin metal salt precipitate from the solution. The present invention still further provides a pharmaceutical composition for alleviating inflammation and pain comprising an anti-inflammatory and analgesically effective amount of salts of indomethacin produced by the process of the invention together with a pharmaceutically acceptable carrier, diluent and/or excipient.
Patent NZ-248796-A (NZ)
Title: Container; outside container surface has recesses with rounded corner portions of certain radius configured to facilitate handling
Inventor: WEAVER EDMUND ALOYSIOUS
IPC: B65D23/10
Filed: 1993-09-28
Abstract: A food product container (10) comprising upstanding front (12) and back (14) walls, a pair of upstanding side walls (16), a generally horizontal bottom (18) and an upper mouth portion having a shoulder area (28) sloping downwardly therefrom, wherein the front and back walls (12, 14) have recesses (30) therein which are configured to co-operate with one another to facilitate manual gripping of the container (10) by the hand of the user spanning one side wall (16) of the container, with the user's thumb and one or more fingers opposed thereto engaging opposite recess surfaces. Each of the recesses (30) preferably comprises a recessed panel having an outwardly convex, generally rectangular central portion (32) and a rim (34) angled outwardly from the central portion (32). A ridge (35) having a relatively small radius of curvature is defined about the outer periphery of the rim (34). At each upper corner, the ridge (35) has an arcuate configuration and curves slightly outward relative to the depth of the container (10). The container (10) is suitable for use with viscous food products, and in a preferred embodiment has a capacity of about 1/2  gallon (about 1.89 l). <IMAGE>
Patent NZ-254181-A (NZ)
Title: Insect trap, insects exposed to insecticidal particles carrying electrostatic charge
Inventor: HOWSE PHILIP EDWIN
IPC: A01M1/04
Filed: 1993-07-09
Abstract: PCT No. PCT/GB93/01442 Sec. 371 Date Jun. 9, 1995 Sec. 102(e) Date Jun. 9, 1995 PCT Filed Jul. 9, 1993 PCT Pub. No. WO94/00980 PCT Pub. Date Jan. 20, 1995Pest control wherein at least part of a pest is exposed to particles which carry an electrostatic charge, preferably of opposite polarity to that of the surface of the pest, and which may be sticky or tacky and comprise a wax, for example, a plant wax, such as, Carnauba wax, or an inorganic material, such as, talc. A pesticide, such as, a chemical or microbial insecticide, or a behavior modifying chemical may be associated with the particles which may also be dispensed in and/or dispersed via a liquid or gaseous carrier, possibly from a pressurized gas or aerosol dispenser at whose nozzle the particles are charged electrostatically by friction. In a preferred embodiment, a trap with a lure (45, 53) has a surface (34), preferably sloping, coated with the particles for destabilizing pests and a trapping zone (41, 43) into which destabilized pests fall from the particle-coated surface (34) and are retained for subsequent disposal.
Patent NZ-262883-A (NZ)
Title: Lightweight formwork module for walls:spacer ties moulded into & through walls of module and forming attachment means on exterior surfaces
Inventor: MENSEN JAN HENDRIK
IPC: E04B2/86
Filed: 1994-03-31
Abstract: The invention provides a building component comprising first and second high density foam panels each having inner and outer surfaces, top and bottom, and first and second ends, the panels arranged in spaced parallel relationship with their inner surfaces facing each other, and at least two bridging members extending between and through and molded into the panel members, each bridging member comprising a pair of elongated end plates oriented in the top to bottom direction of the panels and abutting against the outer surfaces of the panels, and at least one web member extending between and rigidly connected to the end plates, each web member oriented in the top to bottom direction of the panels and having a height substantially less than the height of the panels.
Patent NZ-278593-A (NZ)
Title: Estradiol penetration enhancement from transdermal application
Inventor: MECONI REINHOLD
IPC: A61K9/70
Filed: 1995-01-05
Abstract: PCT No. PCT/EP95/00032 Sec. 371 Date Oct. 11, 1996 Sec. 102(e) Date Oct. 11, 1996 PCT Filed Jan. 5, 1995 PCT Pub. No. WO95/19162 PCT Pub. Date Jul. 20, 1995An active substance-containing patch for the controlled release of estradiol or its pharmaceutically acceptable derivatives alone or in combination with gestagens from a backing layer, an active substance-containing reservoir connected thereto and produced by using pressure sensitive adhesives and at least one penetration enhancer, and a removable protective layer is characterized by the fact that the penetration enhancer is selected from substances based on carboxylic acids.
Patent NZ-330886-A (NZ)
Title: Tropane derivatives, their preparation and use
Inventor: SCHEEL-KRUGER JORGEN
IPC: A61P25/28
Filed: 1997-02-21
Abstract: The present invention relates to novel tropane-derivatives which are valuable monoamine neurotransmitter, i.e dopamine, serotonin and noradrenaline, re-uptake inhibitors and the use of the novel tropane derivatives for the treatment of disorders or diseases responsive to the inhibition of monoamine neurotransmitter re-uptake, such as Parkinson's disease, depression, obsessive compulsive disorders, panic disorders, dementia, memory deficits, attention deficit hyperactivity disorder, obesity, anxiety, eating disorders and drug addiction or misuse, including cocaine abuse.
Patent NZ-336038-A (NZ)
Title: Stable highly active compositions of avidin with an inert support material (agar) a bulking agent and a protectant for separation
Inventor: BURTON STEVEN J
IPC: C12P21/06
Filed: 1996-10-28
Abstract: A stable aqueous slurry or suspension of avidin immobilized on an inert support material comprising 1)	an immobilized avidin/inert support component 2)	1 - 50% by weight of a bulking agent  selected from nonionic water soluble compounds, eg simple sugars. 3)	0.01 - 50% by weight of a protectant  The composition is in lyophilized form and is used to improve avidin/biotin affinity.
Patent NZ-337324-A (NZ)
Title: Enhanced shelf-life pressurized container with ribbed appearance
Inventor: NAHILL THOMAS E
IPC: B65D1/02
Filed: 1998-02-13
Abstract: Pressurized plastic container having the appearance of ribs but with substantially reduced creep and without delamination, i.e., having an enhanced shelf life compared to prior art ribbed containers. In multilayer containers, the scribe lines reduce delamination of the layer structure so as to avoid loss of transparency and/or barrier properties. The reduction in creep is particularly useful for smaller volume containers having a greater surface area to volume ratio.
Patent NZ-508197-A (NZ)
Title: Fortification of foodstuff with a blend of calcium carbonate, calcium lactate and glucuronic acid
Inventor: MALLANGI CHANDRASEKHAR R
IPC: A23L1/304
Filed: 1999-06-14
Abstract: A fortified milk or dairy based food stuff comprises a fortifying amount of a source of calcium consisting of a balanced blend of calcium lactate and calcium carbonate stabilized with a source of glucuronic acid. Also described is a process fro preparing the fortified milk or dairy based food stuff.  Preferably the source of glucuronic acid is gum Arabic.
Patent NZ-514707-A (NZ)
Title: Method of labeling a nucleic acid amplicon with simultaneous contamination prevention
Inventor: DATTAGUPTA NANIBHUSHAN
IPC: C12Q1/6816
Filed: 2000-03-08
Abstract: A composition for labeling and decontaminating a nucleic acid amplification reaction product comprising: A binding ligand comprising a chemical moiety that binds to a nucleic acid ant that, when activated by light, forms at least one covalent bond therewith; A binding enhancer comprising a chemical moiety that has a specific affinity for nucleic acids; and A label comprising a detectable chemical moiety, Wherein said binding ligand, binding enhancer and label are bound together in the form of a covalent or noncovalent complex.
Patent NZ-518364-A (NZ)
Title: Method for the use of soy protein in the production of fresh and ripened cheese
Inventor: BORDERS CHERYL
IPC: A23C19/055
Filed: 2000-09-28
Abstract: A method for making a fresh, unripened cheese analog containing soy protein comprising, (a) mixing isolated soy protein and milk; (b) coagulating the mixture in (a); (c) cutting the product resulting from (b); (d) agitating the product resulting from (c) for about 0 to about 90 minutes at a temperature from about 30 ºC. to about 50 ºC.; (e) separating about 50% to about 80% by weight of whey from product resulting from (d) and salting; and (f) placing product resulting from (e) in molds at a temperature of at least about 28 ºC. for about 2 to about 8 hours and (g) subjecting the molded product from step (f) to external pressure.
Patent NZ-519513-A (NZ)
Title: Infant formula with improved protein content
Inventor: BINDELS JACOB GEERT
IPC: A23L33/00
Filed: 2000-12-13
Abstract: The disclosure relates to an infant formula, comprising a) at least one protein component; and b) at least one lipid component that can be easily digested by an infant; and optionally one or two of: c) at least one prebiotic component; d) at least one viscosity improving component; and optionally one or more components of infant formula known per se, characterised in that: the protein component a) has a phosphorous content of less than 0.75 g P/100 g protein. The formula is preferably further characterised in that the at least one lipid component b) comprises at least one fatty acid triglyceride and/or a mixture of fatty acid triglycerides, in which: - palmitic acid residues make up more than 10 % all fatty acid residues present in the triglycerides; and the triglycerides in which the palmitate residue is in the Sn1- or Sn3- position make up no more than 16 % of all triglycerides present. The disclosure also relates to a method for preparing a protein hydrolysate, in particular for use in the formula of the invention.
Patent NZ-521138-A (NZ)
Title: Blood pump
Inventor: SCHULTE EISTRUP SEBASTIAN
IPC: F04D13/06
Filed: 2001-03-05
Abstract: The invention relates to a blood pump, especially to a ventricular heart-assist pump, comprising a blood chamber which is provided in a pump case and which is configured for accommodating a rotor that can rotate around a rotor axle. An inlet that can be connected to an inflow cannula is configured at least in sections on each of the opposing ends of said blood chamber. An outlet of the blood chamber, which can be connected to an outflow cannula, extends in a direction vertical to the rotor axle, and the rotor axle is rotatably mounted on each side in mechanically active bearings which are provided in the vicinity of a respective inlet and which are joined to the pump housing.
Patent NZ-522091-A (NZ)
Title: Composite building components
Inventor: HOIE TOR H
IPC: E04C2/26
Filed: 2001-03-22
Abstract: A structural insulated panel having a core (40) of expanded polystyrene sandwiched between, and bonded to, two facings (52). The facings are attached to faces of the core formed by moulding. Preferably the core is an expanded polymer moulding and the preferred polymer is polystyrene. The panel is useful as a building component.
Patent NZ-527696-A (NZ)
Title: Conveyor belt cleaning system
Inventor: HALL JOHN
IPC: B65G45/16
Filed: 2002-02-22
Abstract: A conveyor belt cleaning system (100) includes a torsion blade holder assembly having a blade support sub-assembly and a mounting sub-assembly having a first hollow member (102) and a second member (104) situated therein with torsion elements (108) in space between the two members. The second member supports the blade support sub-assembly such that when the scraper blade is biased against the surface of the conveyor belt by the torsion elements. The blade support sub-assembly includes notched receiving members (110) for receiving the scraper blade (114), a face plate (118) extending between the notched receiving members approximately parallel to the scraper blade such that the scraper blade rests flush against the face plate. A horizontal blade stabilizer (120) extends beneath the face plate so that one or more adjustable lock bolts (122) extending upward through the horizontal blade stabilizer may adjust the scraper blade up and down within the notched receiving members.
Patent NZ-528214-A (NZ)
Title: Diagnostic assay for detecting HBV nucleic acids encoding a surface antigen in a sample
Inventor: OON CHONG JIN
IPC: C12N15/09
Filed: 2001-05-23
Abstract: A method for detecting an HBV-derived nucleic acid target sequence in a sample comprises subjecting the sample to denaturing conditions to yield single stranded forms of the target sequence then contacting the sample with a set of primer which comprises at least two primers selected from: SEQ ID NO:1 ( caaggtatgttgcccgtttgt ) and SEQ ID NO:2 ( tggctcagtttactagtgccatt ), primers complementary to SEQ ID NO:1 and 2 and primers having at least 70% similarity thereto. The primers hybridize to regions corresponding to or flanking a conserved nucleotide sequence within or part of the nucleotide sequence encoding HbsAG, wherein at least one primer is capable of hybridizing to one strand of the target sequence and the other primer is capable of hybridizing to a strand complementary and wherein the primers are extendable from their 3' termini to form an extension product complementary to the strand to which each of the primers has hybridized. The sample is then subjected to conditions to facilitate amplification and then detecting for the presence of the amplification product wherein the presence of the amplified product indicates HBV-derived nucleic acid target sequence. One of the primers may be immobilized to a solid support with the other primer in a solution phase. Also described is an array of two or more oligonucleotide primers immobilized to a solid support . (62) Divided out of 511883
Patent NZ-533443-A (NZ)
Title: Detection of immunological memory, T-cell conjugates for pathology imaging and therapy
Inventor: GUNDERSEN HANS JORGEN GOTTLIEB
Filed: 2001-03-22
Abstract: A method of producing labelled T-cells adapted to migrate to the location of an antigen producing microorganism, cell or cell cluster in a mammal or other localised process generated in response to a pathogen, comprises conjugating a detectable label to T-cells which have been purified or selectively multiplied to have a specificity of an antigen produced by the antigen producing microorganism, cell, cell cluster or process. The label is preferably a radio label, an X-ray contrast label, an MR contrast label such as a Ferrous MR-contrast agent or a Gd-MR-contrast agent, or fluorescent label. Also described is a method for determining the location of an antigen producing microorganism, cell or cell cluster in a mammal or another localised process, comprising subjecting the mammal to a scanning process. The mammal has been administered labelled T-cells which have been allowed to migrate to the location of the antigen producing microorganism, cell or cell cluster or localised process, the scanning process serves to detect the location of the migrated T-cells from the label.
Patent NZ-538493-A (NZ)
Title: Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
Inventor: LULLA AMAR
IPC: A61K31/167
Filed: 2003-08-29
Abstract: Disclosed are pharmaceutical products and compositions for use in the treatment of asthma and related disorders, and especially but not exclusively for the treatment of chronic pulmonary disease (COPD). More particularly the pharmaceutical products and compositions comprise specific anticholinergic agents, beta-2 agonists and corticosteroids.
Patent NZ-542486-A (NZ)
Title: Waste treatment apparatus for use in sterilisation of infectious or quarantined waste
Inventor: BUTLER MARK HENRY
IPC: A61L11/00
Filed: 2002-12-11
Abstract: Waste treatment apparatus (200) includes a hopper (201) having an inlet for receiving waste material, a first waste treatment chamber (202), a shredder mechanism (230) operative to effect a first cutting treatment of the waste material as the waste material is discharged from the hopper (201) to the first waste treatment chamber (202), a second cutting mechanism (250) within the first waste treatment (202) chamber operative to effect a second cutting treatment of the waste material before it is discharged to a second treatment chamber (203), a gate mechanism to discharge the treated waste material from the apparatus; and means for introducing steam into the first and second treatment chambers (202 and 203). (62) Divided Out of 532695
Patent NZ-545714-A (NZ)
Title: Steering angle sensor arrangement structure of vehicle intended for rough road use
Inventor: MAKABE TAKUMI
Filed: 2006-03-06
Abstract: A removable steering angle sensor for a motor-driven power steering apparatus for use in a vehicle intended for rough road use. The handlebar of the vehicle is disposed on an upper portion of a steering shaft, and a motor-driven power steering apparatus, including a power assist portion as an actuator unit, is disposed in a middle portion of the steering shaft. The steering angle sensor for detecting a steering angle is disposed on one end of the steering shaft, or more specifically, on a lower end portion of an output shaft, or a leading end portion of an output shaft. During maintenance, this arrangement provides for easy removal and installation of the steering angle sensor.
Patent NZ-549330-A (NZ)
Title: 2H or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
Inventor: DUBOIS LAURENT
IPC: C07D401/12
Filed: 2005-05-10
Abstract: Disclosed are benzo[e]indazol-1-yl carbamate derivatives as represented by the general formula (I) in which W represents an oxygen or sulphur atom; R1 and R2 each represent, independently of one another, an aryl, benzyl or alkyl group; or else R1 and R2 form, with the nitrogen atom which carries them, a heterocycle optionally substituted by one or more alkyl or benzyl groups; and wherin the other substituents are as defined herein; in the form of the base or of an addition salt with an acid, and in the hydrate or solvate form. Also disclosed is the use of a compound as defined above for the preparation of a medicament intended to prevent or treat a pathology in which peripheral-type benzodiazepine receptors are involved (conditions such as peripheral neuropathies, motor neuron conditions, neurodegenerative diseases of the central nervous system, anxiety, epilepsy, sleep disorders, acute or chronic renal insufficiency, glomerulonephritis, diabetic nephropathy, cardiac ischaemia and cardiac insufficiency, myocardial infarction, ischaemia of the lower limbs, coronary vasospasm, angina pectoris, pathologies associated with the heart valves, inflammatory heart diseases, side effects due to cardiotoxic medicaments or as a result of heart surgery, atherosclerosis and its thromboembolic complications, restenosis, graft rejections, conditions related to incorrect proliferation or incorrect migration of smooth muscle cells, tumours and cancers, cutaneous stress, chronic inflammatory diseases, in particular rheumatoid arthritis, and pulmonary inflammatory diseases).